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Fig 1. Facial erythromelalgia mimicking connective tissue
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http://dx.doi.org/10.1016/j.jaad.2014.08.012disease. Biopsy showed vacuolar interface alteration
(arrows), perivascular lymphocytic inflammation, and
marked vascular congestion (right). Mucin deposition
was also evident in the mid to deep dermis (not shown).
(Hematoxylin and eosin; original magnification 3400.)Facial erythromelalgia: A rare entity to
consider in the differential diagnosis of
connective tissue diseases
To the Editor: A 53-year-old man presented to an
outside dermatologist with an erythematous facial
eruption of 4 years’ duration. The eruption was
associated with burning and swelling, which the
patient reported worsenedwith sun exposure. These
symptoms were debilitating, preventing the patient
from working and maintaining daily activities.
Initially, the eruption was thought to be rosacea
and actinic damage; however, it was unresponsive to
standard therapies. Given the refractory nature of the
facial erythema and reported photosensitivity, a
diagnosis of connective tissue disease (CTD)
was considered. Antinuclear, anti-Ro/SSA, and
anti-La/SSB antibodies were negative; however,
skin biopsy revealed vacuolar interface alteration
with perivascular and periadnexal lymphoid
infiltration and mucin deposition (Fig 1). A diagnosis
of CTD was made, and treatment with hydroxy-
chloroquine and systemic corticosteroids was
initiated. However, the patient had minimal clinical
response, resulting in subsequent referral to our CTD
clinic for management. On our initial examination,
the patient had prominent full facial and auricular
erythema and edema, as well as erosions of the
bilateral helices and a violaceous appearance of
his earlobes (Fig 2, A). Despite the biopsy
findings, clinical exam did not support a diagnosis
of CTD. Instead, facial erythromelalgia was
suspected. Upon further questioning, the patient
reported skin burning not only with sun exposure,
but also with heat exposure. Furthermore, he
reported attempting cooling measures, such as the
frequent use of ice packs, to relieve his symptoms.
With these additional details, a clinical diagnosis
of facial and auricular erythromelalgia was estab-
lished. Further workup excluded potential causes
of secondary erythromelalgia. Given thatOpen access under CC BY-NC-ND license.erythromelalgia is thought to involve both small
fiber neuropathy as well as vasculopathy, we initi-
ated therapy with aspirin, pentoxifylline, and gaba-
pentin.1 Subsequently, nifedipine was added to this
treatment regimen. At 5 months’ follow-up, the
patient reported 80% improvement (Fig 2, B) and
was able to return to work and enjoy normal daily
activities.
Erythromelalgia is a rare condition characterized
by episodic erythema, swelling, warmth, and
burning, which can become persistent over time.
Although it primarily occurs on the extremities, it
may also manifest on the ears and face. Heat
exposure triggers episodes, and cooling can alleviate
symptoms.2 Erythromelalgia can cause significant
morbidity andmortality, with suicide being a notable
cause of death, making timely recognition and
initiation of therapy essential.3 There is no diagnostic
test for erythromelalgia; therefore, a high level of
clinical suspicion, along with a detailed history and
physical exam, is required to establish the diagnosis.
Although biopsy findings are often nonspecific,
there has been 1 reported case of histopathologic
findings of CTD in a patient with erythromelalgia
involving the hands.4
This case highlights a rare condition, which can be
mistaken for CTD, particularly when the patient
presents with facial erythema, reports photo-
sensitivity, or has skin biopsy findings that support
CTD. To our knowledge, we report the first case
of facial erythromelalgia with biopsy findings
demonstrating vacuolar interface dermatitis and
mucin deposition. This case underscores the need
for physicians who follow patients with CTD to be
aware of the clinical presentation of facial
erythromelalgia.
Fig 2. A, Facial erythromelalgia before therapy. There is prominent full facial erythema and
edema, which may mimic the facial erythema seen in connective tissue diseases. B, Facial
erythromelalgia after treatment. Improvement in erythema and edema 5 months following
initiation of therapy with aspirin, pentoxifylline, gabapentin, and, subsequently, nifedipine.
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manifestation of cutaneous macroglobulinosis
To the Editor: In December 2013, a 70-year-old
man came to our service for nodules covered by a
thick hyperkeratotic layer on the soles of his feet.
The lesions were extremely painful to pressure, to
the extent of limiting his daily activities (Fig 1). They
had appeared about 2 years earlier and were treated
as viral warts with keratolytic agents, without
success.
The patient’s history showed that he had been
followed by the hematology service for 15 years with
periodic clinical evaluations and no therapy for a
diagnosis of Waldenstr€om macroglobulinemia
(WM). The most recent laboratory studies were
unremarkable with no detectable anti-myelin-
associated glycoprotein (anti-MAG) or cryoglobulin.
Serum immunofixation studies revealed the
presence of an IgM-kappa monoclonal protein of
22.9 g/L (0.4-2.5 g/L); urine analysis identified
Bence-Jones (IgM-kappa type) proteinuria. The
patient was otherwise in good health.
On the basis of clinical and laboratory findings,
hematologists recommended no therapy.
A biopsy of 1 of the plantar nodules showed
hyperplastic and hyperkeratotic epidermis, and
moderate perivascular lymphohistiocytic inflamma-
tion with rare plasma cells. In the dermis and in
the intravascular space there was deposition of
an amorphous, homogeneous, intensely periodic
acid-Schiffpositive and Congo rednegative
material. The biopsy specimen was IgM positive
when immunohistochemical stains were used
(Fig 2). Based on the clinical course, histology, and
anamnestic data, we considered a diagnosis of
